Medication-Assisted Treatment
Medication-assisted treatment (MAT) is a treatment for substance use disorders that combines medication with behavioral therapies
Executive Briefing | Dec 20, 2024
Medication-assisted treatment (MAT) for opioid use disorder (OUD) has been referred to as the “gold standard” (see Facing Addiction In America: The Surgeon General’s Spotlight On Opioids) for treatment. But that endorsement hasn’t been enough to drive the adoption of MAT. Health and human service (HHS) executives—at the policy and practice level—are trying to drive the use…
Executive Briefing | Feb 4, 2025
Executive Briefing | Jan 29, 2025
Executive Briefing | Feb 1, 2025
Executive Briefing | Aug 8, 2024
Executive Education On-Demand | Nov 1, 2023
This presentation took place at The 2023 OPEN MINDS Technology & Analytics Institute at the first-ever OPEN MINDS Smart Home Expo. Yeardley Green, Executive Vice President Of Sales & Business Development of Altruix showcased Medherent, a smart medication vending machine. The machine achieves independence while improving staff efficiency and medication safety. Enabled by Blue-tooth, the device alerts consumers when…
Altruix is a behavioral health pharmacy dedicated to individuals with serious and persistent mental illness and intellectual & developmental disabilities. Altruix pharmacies serve this population through high-touch relationships with community-based behavioral health agencies, group homes, and other care providers. Altruix’s comprehensive suite of value-added pharmacy services and technology drives quantifiable improvements in medication adherence for the most complex behavioral health patients while easing the costly administrative burden for their caregivers. Altruix customers achieve improved outcomes such as 90% adherence and 40% fewer dollars spent on ER and hospital visits. For more information, visit www.altruix.com.
